DocMorris Valuation

Q: What is the Fair Price of ROSEZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ROSEZ (CHF34.38) is trading below our estimate of [[fair value]] (CHF200.17)

Is ROSEZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ROSEZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ROSEZ (CHF34.38) is trading below our estimate of fair value (CHF200.17)

Significantly Below Fair Value: ROSEZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ROSEZ?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for ROSEZ. This is calculated by dividing ROSEZ's market cap by their current preferred multiple.
What is ROSEZ's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CHF 400.44m

ROSEZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.5x
Enterprise Value/EBITDA	-5.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does ROSEZ's PS Ratio compare to its peers?

The above table shows the PS ratio for ROSEZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.9x
KITW Kitwave Group	0.4x	6.4%	UK£239.1m
FIXP Fix Price Group	0.5x	n/a	US$1.6b
CBOX Cake Box Holdings	1.8x	8.1%	UK£69.0m
OCDO Ocado Group	0.8x	8.2%	UK£2.4b
ROSEZ DocMorris	0.2x	5.7%	CHF 400.4m

Price-To-Sales vs Peers: ROSEZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (16.2x).

Price to Earnings Ratio vs Industry

How does ROSEZ's PE Ratio compare vs other companies in the European Consumer Retailing Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	8.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	8.4%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: ROSEZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Consumer Retailing industry average (0.3x).

Price to Sales Ratio vs Fair Ratio

What is ROSEZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ROSEZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	0.2x

Price-To-Sales vs Fair Ratio: ROSEZ is expensive based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ROSEZ forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Jun ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
May ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Apr ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Mar ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Feb ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Jan ’25	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Dec ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Nov ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Oct ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Sep ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Aug ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Jul ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
Jun ’24	n/a	CHF 54.25 0%	23.4%	CHF 80.00	CHF 31.00	n/a	12
May ’24	CHF 38.82	CHF 53.62 +38.1%	23.1%	CHF 80.00	CHF 31.00	n/a	13
Apr ’24	CHF 42.18	CHF 54.62 +29.5%	22.7%	CHF 80.00	CHF 31.00	n/a	13
Mar ’24	CHF 48.86	CHF 54.33 +11.2%	19.3%	CHF 71.00	CHF 31.00	n/a	12
Feb ’24	CHF 33.38	CHF 37.96 +13.7%	61.4%	CHF 106.00	CHF 19.00	n/a	12
Jan ’24	CHF 25.66	CHF 53.96 +110.3%	97.9%	CHF 210.00	CHF 19.00	n/a	12
Dec ’23	CHF 27.60	CHF 54.04 +95.8%	97.7%	CHF 210.00	CHF 19.00	n/a	12
Nov ’23	CHF 28.14	CHF 54.96 +95.3%	95.2%	CHF 210.00	CHF 19.00	n/a	12
Oct ’23	CHF 29.70	CHF 81.36 +174.0%	59.4%	CHF 210.00	CHF 35.00	n/a	11
Sep ’23	CHF 40.80	CHF 82.70 +102.7%	40.0%	CHF 149.00	CHF 49.00	n/a	10
Aug ’23	CHF 68.13	CHF 145.82 +114.0%	46.4%	CHF 290.00	CHF 73.00	n/a	11
Jul ’23	CHF 75.00	CHF 165.92 +121.2%	38.5%	CHF 290.00	CHF 73.00	n/a	12
Jun ’23	CHF 111.80	CHF 197.45 +76.6%	46.7%	CHF 420.00	CHF 95.00	n/a	11

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.